nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP1A2—chronic obstructive pulmonary disease	0.535	1	CbGaD
Secobarbital—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.052	0.227	CbGbCtD
Secobarbital—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0479	0.209	CbGbCtD
Secobarbital—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0479	0.209	CbGbCtD
Secobarbital—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0452	0.197	CbGbCtD
Secobarbital—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0363	0.158	CbGbCtD
Secobarbital—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00237	0.0231	CcSEcCtD
Secobarbital—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.0205	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.0201	CcSEcCtD
Secobarbital—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00199	0.0195	CcSEcCtD
Secobarbital—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0181	CcSEcCtD
Secobarbital—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00174	0.017	CcSEcCtD
Secobarbital—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00172	0.0168	CcSEcCtD
Secobarbital—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.0166	CcSEcCtD
Secobarbital—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.0164	CcSEcCtD
Secobarbital—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.0163	CcSEcCtD
Secobarbital—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.0156	CcSEcCtD
Secobarbital—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.0145	CcSEcCtD
Secobarbital—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.0128	CcSEcCtD
Secobarbital—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.012	CcSEcCtD
Secobarbital—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0115	CcSEcCtD
Secobarbital—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.0112	CcSEcCtD
Secobarbital—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.0111	CcSEcCtD
Secobarbital—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.0105	CcSEcCtD
Secobarbital—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.0103	CcSEcCtD
Secobarbital—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00984	CcSEcCtD
Secobarbital—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000995	0.00973	CcSEcCtD
Secobarbital—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00099	0.00969	CcSEcCtD
Secobarbital—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000987	0.00966	CcSEcCtD
Secobarbital—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000968	0.00946	CcSEcCtD
Secobarbital—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000945	0.00924	CcSEcCtD
Secobarbital—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000937	0.00917	CcSEcCtD
Secobarbital—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000908	0.00889	CcSEcCtD
Secobarbital—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000901	0.00881	CcSEcCtD
Secobarbital—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0009	0.0088	CcSEcCtD
Secobarbital—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000895	0.00875	CcSEcCtD
Secobarbital—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00089	0.00871	CcSEcCtD
Secobarbital—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000884	0.00865	CcSEcCtD
Secobarbital—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.00853	CcSEcCtD
Secobarbital—Tension—Formoterol—chronic obstructive pulmonary disease	0.000872	0.00853	CcSEcCtD
Secobarbital—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000863	0.00844	CcSEcCtD
Secobarbital—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000863	0.00844	CcSEcCtD
Secobarbital—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000849	0.0083	CcSEcCtD
Secobarbital—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00805	CcSEcCtD
Secobarbital—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000816	0.00799	CcSEcCtD
Secobarbital—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000816	0.00799	CcSEcCtD
Secobarbital—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000815	0.00797	CcSEcCtD
Secobarbital—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000812	0.00794	CcSEcCtD
Secobarbital—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000812	0.00794	CcSEcCtD
Secobarbital—Agitation—Montelukast—chronic obstructive pulmonary disease	0.0008	0.00782	CcSEcCtD
Secobarbital—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000795	0.00778	CcSEcCtD
Secobarbital—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00754	CcSEcCtD
Secobarbital—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00752	CcSEcCtD
Secobarbital—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000767	0.0075	CcSEcCtD
Secobarbital—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000754	0.00737	CcSEcCtD
Secobarbital—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.00737	CcSEcCtD
Secobarbital—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000753	0.00737	CcSEcCtD
Secobarbital—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00736	CcSEcCtD
Secobarbital—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000738	0.00722	CcSEcCtD
Secobarbital—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00721	CcSEcCtD
Secobarbital—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00696	CcSEcCtD
Secobarbital—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000702	0.00687	CcSEcCtD
Secobarbital—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000698	0.00682	CcSEcCtD
Secobarbital—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000678	0.00663	CcSEcCtD
Secobarbital—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000678	0.00663	CcSEcCtD
Secobarbital—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.00659	CcSEcCtD
Secobarbital—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00648	CcSEcCtD
Secobarbital—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00631	CcSEcCtD
Secobarbital—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00631	CcSEcCtD
Secobarbital—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00064	0.00626	CcSEcCtD
Secobarbital—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00618	CcSEcCtD
Secobarbital—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00063	0.00616	CcSEcCtD
Secobarbital—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.00607	CcSEcCtD
Secobarbital—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00062	0.00607	CcSEcCtD
Secobarbital—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00595	CcSEcCtD
Secobarbital—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000606	0.00593	CcSEcCtD
Secobarbital—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000601	0.00588	CcSEcCtD
Secobarbital—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0006	0.00587	CcSEcCtD
Secobarbital—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00584	CcSEcCtD
Secobarbital—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00584	CcSEcCtD
Secobarbital—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00584	CcSEcCtD
Secobarbital—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000594	0.00581	CcSEcCtD
Secobarbital—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00573	CcSEcCtD
Secobarbital—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000573	0.00561	CcSEcCtD
Secobarbital—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.00561	CcSEcCtD
Secobarbital—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00559	CcSEcCtD
Secobarbital—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00554	CcSEcCtD
Secobarbital—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00554	CcSEcCtD
Secobarbital—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000566	0.00554	CcSEcCtD
Secobarbital—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00552	CcSEcCtD
Secobarbital—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000563	0.00551	CcSEcCtD
Secobarbital—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000563	0.0055	CcSEcCtD
Secobarbital—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00549	CcSEcCtD
Secobarbital—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00529	CcSEcCtD
Secobarbital—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.00523	CcSEcCtD
Secobarbital—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000534	0.00523	CcSEcCtD
Secobarbital—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000534	0.00522	CcSEcCtD
Secobarbital—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00512	CcSEcCtD
Secobarbital—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00493	CcSEcCtD
Secobarbital—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00469	CcSEcCtD
Secobarbital—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00469	CcSEcCtD
Secobarbital—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00459	CcSEcCtD
Secobarbital—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00451	CcSEcCtD
Secobarbital—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00451	CcSEcCtD
Secobarbital—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00447	CcSEcCtD
Secobarbital—Rash—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00447	CcSEcCtD
Secobarbital—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00447	CcSEcCtD
Secobarbital—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00447	CcSEcCtD
Secobarbital—Headache—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00444	CcSEcCtD
Secobarbital—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00444	CcSEcCtD
Secobarbital—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00443	CcSEcCtD
Secobarbital—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00442	CcSEcCtD
Secobarbital—Rash—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00438	CcSEcCtD
Secobarbital—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00438	CcSEcCtD
Secobarbital—Headache—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00435	CcSEcCtD
Secobarbital—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00044	0.0043	CcSEcCtD
Secobarbital—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00426	CcSEcCtD
Secobarbital—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00422	CcSEcCtD
Secobarbital—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000431	0.00422	CcSEcCtD
Secobarbital—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00422	CcSEcCtD
Secobarbital—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000431	0.00421	CcSEcCtD
Secobarbital—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.00421	CcSEcCtD
Secobarbital—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00043	0.00321	CbGpPWpGaD
Secobarbital—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.0042	CcSEcCtD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000429	0.00321	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000428	0.0032	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000428	0.0032	CbGpPWpGaD
Secobarbital—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000423	0.00414	CcSEcCtD
Secobarbital—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000422	0.00413	CcSEcCtD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000421	0.00315	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000414	0.00309	CbGpPWpGaD
Secobarbital—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000413	0.00309	CbGpPWpGaD
Secobarbital—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000409	0.004	CcSEcCtD
Secobarbital—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00398	CcSEcCtD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000404	0.00302	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000403	0.00301	CbGpPWpGaD
Secobarbital—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00391	CcSEcCtD
Secobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000398	0.00298	CbGpPWpGaD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000393	0.00294	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000388	0.0029	CbGpPWpGaD
Secobarbital—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000386	0.00378	CcSEcCtD
Secobarbital—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000384	0.00287	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000377	0.00282	CbGpPWpGaD
Secobarbital—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000369	0.00276	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000367	0.00275	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000363	0.00271	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000361	0.0027	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00269	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00269	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000353	0.00264	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000351	0.00262	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00035	0.00261	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000349	0.00261	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000348	0.0026	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000343	0.00257	CbGpPWpGaD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000343	0.00257	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000339	0.00253	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000337	0.00252	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000332	0.00248	CbGpPWpGaD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000329	0.00246	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000328	0.00245	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000328	0.00245	CbGpPWpGaD
Secobarbital—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.00317	CcSEcCtD
Secobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000322	0.00241	CbGpPWpGaD
Secobarbital—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000321	0.00314	CcSEcCtD
Secobarbital—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00313	CcSEcCtD
Secobarbital—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000319	0.00238	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000317	0.00237	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000317	0.00237	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000314	0.00235	CbGpPWpGaD
Secobarbital—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00307	CcSEcCtD
Secobarbital—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000312	0.00233	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000311	0.00233	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00031	0.00232	CbGpPWpGaD
Secobarbital—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00301	CcSEcCtD
Secobarbital—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000306	0.00229	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000306	0.00229	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000305	0.00228	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000303	0.00227	CbGpPWpGaD
Secobarbital—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0003	0.00224	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0003	0.00224	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0003	0.00224	CbGpPWpGaD
Secobarbital—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000297	0.0029	CcSEcCtD
Secobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000296	0.00221	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000294	0.0022	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00029	0.00217	CbGpPWpGaD
Secobarbital—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.00283	CcSEcCtD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000288	0.00215	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000287	0.00215	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000282	0.0021	CbGpPWpGaD
Secobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000281	0.0021	CbGpPWpGaD
Secobarbital—Shock—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00275	CcSEcCtD
Secobarbital—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00028	0.00209	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000278	0.00208	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000276	0.00206	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000272	0.00203	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000271	0.00202	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000269	0.00201	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000268	0.002	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000267	0.002	CbGpPWpGaD
Secobarbital—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00199	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000265	0.00198	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000263	0.00196	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000262	0.00196	CbGpPWpGaD
Secobarbital—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.00254	CcSEcCtD
Secobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000258	0.00193	CbGpPWpGaD
Secobarbital—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00192	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000256	0.00191	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000254	0.0019	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.0019	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000254	0.0019	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000251	0.00188	CbGpPWpGaD
Secobarbital—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00242	CcSEcCtD
Secobarbital—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000247	0.00185	CbGpPWpGaD
Secobarbital—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00242	CcSEcCtD
Secobarbital—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000247	0.00185	CbGpPWpGaD
Secobarbital—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00241	CcSEcCtD
Secobarbital—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00239	CcSEcCtD
Secobarbital—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000243	0.00181	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000238	0.00178	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000238	0.00178	CbGpPWpGaD
Secobarbital—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000235	0.0023	CcSEcCtD
Secobarbital—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.00228	CcSEcCtD
Secobarbital—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000233	0.00174	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00023	0.00172	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000227	0.00169	CbGpPWpGaD
Secobarbital—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00221	CcSEcCtD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000224	0.00168	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000224	0.00168	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000224	0.00167	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00022	0.00164	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00164	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000217	0.00162	CbGpPWpGaD
Secobarbital—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00162	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000216	0.00162	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000212	0.00158	CbGpPWpGaD
Secobarbital—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00206	CcSEcCtD
Secobarbital—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000207	0.00155	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000206	0.00154	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000203	0.00152	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000201	0.00151	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00148	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000198	0.00148	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000196	0.00147	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000194	0.00145	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000194	0.00145	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00019	0.00142	CbGpPWpGaD
Secobarbital—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00185	CcSEcCtD
Secobarbital—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00138	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000183	0.00136	CbGpPWpGaD
Secobarbital—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00177	CcSEcCtD
Secobarbital—Rash—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00176	CcSEcCtD
Secobarbital—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00176	CcSEcCtD
Secobarbital—Headache—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00175	CcSEcCtD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000178	0.00133	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000178	0.00133	CbGpPWpGaD
Secobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00132	CbGpPWpGaD
Secobarbital—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00166	CcSEcCtD
Secobarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000166	0.00124	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00119	CbGpPWpGaD
Secobarbital—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00118	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000156	0.00117	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00112	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000147	0.0011	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00108	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000141	0.00106	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00102	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00102	CbGpPWpGaD
Secobarbital—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00102	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000136	0.00102	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000135	0.00101	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000134	0.000998	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000969	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.000966	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.000958	CbGpPWpGaD
Secobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.000957	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00012	0.000899	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00012	0.000897	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.00012	0.000894	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000115	0.000861	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000114	0.000849	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000112	0.00084	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.000828	CbGpPWpGaD
Secobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.000817	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.000786	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000102	0.000766	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.75e-05	0.000729	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.44e-05	0.000706	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	9.36e-05	0.0007	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.31e-05	0.000696	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.25e-05	0.000691	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.14e-05	0.000683	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.98e-05	0.000672	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	8.6e-05	0.000643	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.35e-05	0.000625	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.27e-05	0.000618	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.99e-05	0.000597	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.9e-05	0.000591	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.87e-05	0.000589	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.81e-05	0.000584	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.77e-05	0.000581	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.68e-05	0.000574	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.58e-05	0.000567	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.58e-05	0.000567	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.43e-05	0.000556	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.24e-05	0.000541	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.14e-05	0.000534	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.13e-05	0.000533	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.86e-05	0.000513	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.82e-05	0.00051	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.77e-05	0.000506	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.74e-05	0.000504	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.74e-05	0.000504	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.5e-05	0.000486	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.42e-05	0.00048	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.41e-05	0.000479	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.32e-05	0.000473	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.16e-05	0.000461	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.04e-05	0.000451	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.99e-05	0.000447	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.89e-05	0.00044	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.89e-05	0.00044	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.88e-05	0.000439	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.81e-05	0.000434	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.78e-05	0.000432	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.78e-05	0.000432	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.78e-05	0.000432	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.63e-05	0.000421	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.000417	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.55e-05	0.000415	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.52e-05	0.000413	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.51e-05	0.000412	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.5e-05	0.000411	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.5e-05	0.000411	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.48e-05	0.000409	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.4e-05	0.000404	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.17e-05	0.000387	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.03e-05	0.000376	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.96e-05	0.000371	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.93e-05	0.000368	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.77e-05	0.000357	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.71e-05	0.000352	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.49e-05	0.000336	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.17e-05	0.000312	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.1e-05	0.000306	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.04e-05	0.000302	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.94e-05	0.000294	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.84e-05	0.000287	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.7e-05	0.000277	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.66e-05	0.000273	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.63e-05	0.000271	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.59e-05	0.000269	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.56e-05	0.000266	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000264	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.47e-05	0.000259	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.38e-05	0.000253	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.31e-05	0.000247	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.2e-05	0.000239	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.98e-05	0.000222	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000221	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.95e-05	0.000221	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.89e-05	0.000216	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.74e-05	0.000205	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.69e-05	0.000201	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.000197	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.54e-05	0.00019	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.47e-05	0.000185	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.3e-05	0.000172	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.14e-05	0.00016	CbGpPWpGaD
Secobarbital—Phenobarbital—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.509	CrCbGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.94e-05	0.000145	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.92e-05	0.000144	CbGpPWpGaD
Secobarbital—Phenobarbital—CYP1A2—chronic obstructive pulmonary disease	1.88e-05	0.491	CrCbGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000137	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.79e-05	0.000134	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.75e-05	0.000131	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.58e-05	0.000118	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.56e-05	0.000117	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.46e-05	0.000109	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000107	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.000101	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.35e-05	0.000101	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	9.99e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.33e-05	9.93e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	9.82e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.25e-05	9.31e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.24e-05	9.25e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	9.11e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	8.77e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	8.19e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.08e-05	8.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	7.53e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.55e-06	7.14e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.37e-06	7e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.24e-06	6.91e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.61e-06	6.43e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.16e-06	6.1e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.97e-06	5.96e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.63e-06	5.7e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.49e-06	4.85e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.21e-06	4.64e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-06	4.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-06	3.97e-05	CbGpPWpGaD
